Literature DB >> 7832806

Down-regulation of interleukin-8 gene expression in HL60 cell line by human Kunitz-type trypsin inhibitor.

K Maehara1, N Kanayama, A Halim, E el Maradny, T Oda, M Fujita, T Terao.   

Abstract

Urinary trypsin inhibitor (UTI) is one of the Kunitz-type protease inhibitors in human. Little is known about its anti-inflammatory functions other than protease inhibition. We studied the effect of UTI on gene expression of interleukin-8 (IL-8), an inflammatory cytokine. UTI inhibited IL-8 gene expression induced by lipopolysaccharide (LPS) in HL60 cells. The IL-8 concentrations in the cells and medium after LPS stimulation increased time-dependently in the absence of UTI, but did not increase in the presence of UTI. On the other hand, UTI did not inhibit either the synthesis or the release of IL-8 induced by the calcium ionophore A23187. UTI inhibited increase of cytosolic Ca2+ stimulated by LPS but not by A23187. Our results suggest that the inhibition by UTI is due to its effect on the cell membrane involved in regulating Ca2+ influx.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7832806     DOI: 10.1006/bbrc.1995.1131

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

1.  Cloning of tobacco genes that elicit the hypersensitive response.

Authors:  E E Karrer; R N Beachy; C A Holt
Journal:  Plant Mol Biol       Date:  1998-03       Impact factor: 4.076

2.  Chemical Synthesis and Anti-Inflammatory Activity of Bikunin Associated Chondroitin Sulfate 24-mer.

Authors:  Sherif Ramadan; Tianlu Li; Weizhun Yang; Jicheng Zhang; Zahra Rashidijahanabad; Zibin Tan; Narayanan Parameswaran; Xuefei Huang
Journal:  ACS Cent Sci       Date:  2020-06-01       Impact factor: 14.553

3.  Levels of Urinary Trypsin Inhibitor and Structure of Its Chondroitin Sulphate Moiety in Type 1 and Type 2 Diabetes.

Authors:  Antonio Junior Lepedda; Gabriele Nieddu; Silvia Rocchiccioli; Nadia Ucciferri; Michela Idini; Pierina De Muro; Marilena Formato
Journal:  J Diabetes Res       Date:  2018-02-06       Impact factor: 4.011

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.